|
Volumn 30, Issue 13, 2011, Pages 2516-2517
|
From DNA binding to metabolic control: Integration of-omics data reveals drug targets for prostate cancer
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANDROGEN;
ANDROGEN RECEPTOR;
ANDROGEN RECEPTOR ANTAGONIST;
CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE KINASE;
PROTEIN CAMKK2;
RNA POLYMERASE II;
UNCLASSIFIED DRUG;
ARTICLE;
DNA BINDING;
DRUG MECHANISM;
DRUG TARGETING;
GENOMICS;
HIGH THROUGHPUT SCREENING;
HUMAN;
METABOLIC REGULATION;
METABOLOMICS;
NONHUMAN;
PRIORITY JOURNAL;
PROSTATE CANCER;
PROTEOMICS;
SIGNAL TRANSDUCTION;
THERAPY RESISTANCE;
TRANSCRIPTOMICS;
ANTINEOPLASTIC AGENTS;
CARCINOMA;
CELL LINE, TUMOR;
DATA INTERPRETATION, STATISTICAL;
DNA;
DNA-BINDING PROTEINS;
DRUG DISCOVERY;
GENOMICS;
HUMANS;
MALE;
METABOLISM;
MODELS, BIOLOGICAL;
MOLECULAR TARGETED THERAPY;
PROSTATIC NEOPLASMS;
PROTEIN BINDING;
PROTEOMICS;
RECEPTORS, ANDROGEN;
SYSTEMS INTEGRATION;
|
EID: 79960049215
PISSN: 02614189
EISSN: 14602075
Source Type: Journal
DOI: 10.1038/emboj.2011.205 Document Type: Article |
Times cited : (3)
|
References (10)
|